CLDX 股东权益历史(2016–2025)
Celldex Therapeutics, Inc. (CLDX) 各财年年末股东权益(来自 SEC 财报)。
$527.2MFY2025 · FY2016 以来:$265.4M → $527.2M
| 财年 | 数值 | 同比 |
|---|---|---|
| FY2025 | $527.2M | -29.4% |
| FY2024 | $747.0M | +74.1% |
| FY2023 | $429.2M | +31.6% |
| FY2022 | $326.2M | -22.2% |
| FY2021 | $419.5M | +100.4% |
| FY2020 | $209.4M | +122.7% |
| FY2019 | $94.0M | -24.2% |
| FY2018 | $124.1M | -47.5% |
| FY2017 | $236.4M | -10.9% |
| FY2016 | $265.4M | — |
数据来自 SEC XBRL 申报 · 仅供参考 · 非投资建议